FDA Clearance Tracker · P150028-S001
Cheatham Platinum (CP) Stent System (Covered CP Stent, Covered Mounted CP Stent, CP Stent, Mounted CP Stent)
Last checked: Nov 20, 2026Latest source record: Oct 24, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2017
Approved
Time to decision
249 days
Received Feb 17, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P150028-S001
- Device name
- Cheatham Platinum (CP) Stent System (Covered CP Stent, Covered Mounted CP Stent, CP Stent, Mounted CP Stent)
- Applicant
- NuMED, Inc.
- Applicant location
- Hopkinton, NY
- Received
- Feb 17, 2017
- Decided
- Oct 24, 2017
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P150028
Device type
- Device type
- Aortic stent (PNF)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Covered CP Stent and Covered Mounted CP Stent Models. This device is indicated for use in the treatment of right ventricle to pulmonary artery (right ventricular outflow tract, RVOT) conduit disruptions that are identified during conduit pre-dilatation procedures performed in preparation for transcatheter pulmonary valve replacement (TPVR). In addition, approval for additional sizes (10-zig and lengths up to 60 mm for 8- and 10-zig configurations) for the Cheatham Platinum Stent System.
Source documents
Other decisions for NuMED, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K213915 · Decided Jan 12, 2022 · 28 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal, Dual-Balloon (NVM) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.